ISPIRE's 2023 Annual Report: Milestone Achieved with Revenue Growth
On September 19, ISPIRE (ISPR.US), a tech company known as "Fog Hemp Technology," released its fiscal year 2023 report. The performance report reveals that ISPIRE experienced a revenue growth of 31.2% in the 2023 fiscal year, reaching a total of $115.6 million.
Michael Wang, Co-CEO of ISPIRE, has described the 2023 fiscal year as a significant milestone for the company. Revenue from CBD and e-cigarette products saw impressive growth of 100.4% and 10.9% respectively, contributing to an overall revenue increase of 31.2%. This growth was primarily driven by a doubling of income from ISPIRE's CBD vaporizer products in the United States and increased sales of e-cigarette products in Europe.
He stated that the key to this success is ISPIRE's multi-pronged strategy: expanding the sales of CBD vaporizer products to provide innovative solutions for both medical and recreational sectors.
He also stated that ISPIRE's factory in California, United States, will launch its first fully automated assembly line by the end of 2023. Furthermore, ISPIRE is actively considering Southeast Asia as a potential manufacturing hub for future business, aiming to further optimize production capacity.
Disclaimer:
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.
